Nghĩa của từ T cell antigen receptor bằng Tiếng Việt


danh từ
thụ thể tế bào T dành cho kháng nguyê

Đặt câu có từ "T cell antigen receptor"

Dưới đây là những mẫu câu có chứa từ "T cell antigen receptor", trong bộ từ điển Từ điển Y Khoa Anh - Việt. Chúng ta có thể tham khảo những mẫu câu này để đặt câu trong tình huống cần đặt câu với từ T cell antigen receptor, hoặc tham khảo ngữ cảnh sử dụng từ T cell antigen receptor trong bộ từ điển Từ điển Y Khoa Anh - Việt

1. Chimeric Antigen Receptor (CAR) T-cell Therapy

2. T-Cell Clonality; T cell antigen receptors, Gene Rearrangement; Laboratory

3. Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of Allogeneic chimeric antigen receptor T cell

4. Chimeric antigen receptor (CAR) T-cell therapy represents a major advancement in personalized cancer treatment. In this strategy, a patient's own T cells are genetically engineered to express a synthetic receptor that binds a tumor antigen.

5. Upon contact with its specific antigen, the T cell receptor transduces an activation signal into the T cell, leading to proliferation, cytokine production, or efficient cytotoxicity.

6. The Company develops Allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors.

7. Here we review the conceptual foundations of T cell Clonality assays, including T cell ontogeny and T cell receptor …

8. Allogene Therapeutics, with headquarters in South San Francisco, is a clinical stage biotechnology company pioneering the development of Allogeneic chimeric antigen receptor T-cell (CAR T

9. Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of Allogeneic chimeric antigen receptor T cell (AlloCAR T

10. Here we review the conceptual foundations of T cell Clonality assays, including T cell ontogeny and T cell receptor structure and function; we also provide an introduction to T cell receptor genomics and the concept of the T cell clonotype.

11. Chimeric Antigen Receptor T Cells This review addresses T-cell engineering and synthetic immunity, with a focus on producing durable remissions in patients with treatment-refractory tumors

12. Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of Allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer

13. Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of Allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer

14. Adoptive T-cell therapies with T-cells modified with chimeric antigen receptors (CAR-T) also causes CRS.

Điều trị miễn dịch ung thư bằng tế bào T đã được sửa đổi có các thụ thể kháng nguyên chimeric (CAR-T) cũng gây ra CRS.

15. A molecule that is capable of binding to an antibody or to an Antigen receptor on a T cell, especially one that induces an immune response

16. An Antigen-specific B cell antibody specifically recognizes a TI-2 Antigen, but without T cell help, a memory response is not seen.

17. Such Bulged pMHC-I complexes represent challenges for T-cell receptor (TCR) ligation, although t …

18. About Allogene Therapeutics Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of Allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer

19. About Allogene Therapeutics Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of Allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer

20. As with B cells, each type of T cell recognizes a different antigen.

Giống như các tế bào B, mỗi loại tế bào T nhận ra một kháng nguyên khác nhau.

21. Clone REA643 recognizes the mouse Allergin-1 antigen, a single-pass transmembrane protein also known as mast cell antigen 32 or allergy inhibitory receptor 1

22. The diagram above represents the process of Chimeric antigen receptor T-cell therapy (CAR), this is a method of immunotherapy, which is a growing practice in the treatment of cancer

23. CD8+ (Cytotoxic) T cells, like CD4+ Helper T cells, are generated in the thymus and express the T-cell receptor

24. The French biotech Servier has an agreement with Allogene Therapeutics, through Pfizer, to market its Allogenic chimeric antigen receptor (CAR) T-cell product in the United States if it receives

25. Anergy is characterised by decreased or absent lymphokine secretion by viable T cells when the T cell receptor is engaged by an antigen; it can be tested by loss of delayed hypersensitivity (e.g., to PPD, Candida antigens or DCNB).